Compositions and methods for treatment of non-Hodgkin's...

Details Compositions and methods for treatment of non-Hodgkin's... Compositions and methods for treatment of non-Hodgkin's...

2005-06-30

2008-08-12

Yu, Misook (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007100

Reexamination Certificate

active

07410772

ABSTRACT:
The present invention is directed to compositions of matter useful for the treatment of non-Hodgkin's lymphoma in mammals and to methods of using those compositions for the same.

REFERENCES:
patent: WO 98/21332 (1998-05-01), None
patent: 99/00117 (1999-01-01), None
patent: WO 99/31117 (1999-06-01), None
patent: WO 00/60076 (2000-10-01), None
patent: WO 00/77037 (2000-12-01), None
patent: WO 01/19988 (2001-03-01), None
patent: WO 01/68848 (2001-09-01), None
patent: WO 02/08284 (2002-01-01), None
patent: WO 02/08288 (2002-01-01), None
patent: WO 02/16602 (2002-02-01), None
Zuchi et al., PNAS, 2004, 101:18147-18152.
Nakamura et al., Biochem Biophys Res Comm, 2005, 338:1197-1203.
Greenbaum et al., Genome Biology, 2003, vol. 4, Issue 9, pp. 117.1-117.8.
Marshall et al, “FDC-SP, a novel secreted protein expressed by follicular dendritic cells”J Immunol. 169(5):2381-2389 (Sep. 1, 2002).
“Follicular dendritic cell secreted peptide precursor (FDC-SP) (FDC secreted protein)”Database UniProt(Online) (XP 002374850 retrieved from EBI accession No. Uniprot:Q8NFU4) (Oct. 1, 2002).
Marshall, A.J. et al., “FDC-SP, a novel secreted protein expressed by follicular dendritic cells”FASEB Journal16(4):A721 (Apr. 24, 2002).
Marshall, A.J. et al., “Follicular dendritic cell secreted peptide (FDC-SP) is a novel chemotactic factor specific for B cells activated by T-dependent signals”FASEB(Abstracts of papers. Abstract 774.1), Annual Meeting edition 18(4/5):A1144 (Apr. 2004).
Pan, Zenggang et al., “Two Newly Characterized Germinal Center B-Cell-Associated Genes, GCET1 and GCET2, Have Differential Expression in Normal and Neoplastic B Cells”American Journal of Pathology163(1):135-144 (Jul. 2003).

Affiliated with

Also associated with

Rating

Compositions and methods for treatment of non-Hodgkin's... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for treatment of non-Hodgkin's..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treatment of non-Hodgkin's... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4019519